Supplements

TAKE ACTION: Oppose FDA's Restriction on BHRT

Washington, DC - In January, the FDA decided to restrict women's access to estriol and bio-identical hormone replacement therapy (BHRT). Take action and preserve your right to make your own health decisions.

Washington, DC - An attack is under way against a woman's right to know as well as her access to bio-identical hormone replacement therapy (BHRT), and the information women need to make their own health decisions is in jeopardy. read more

TAKE ACTION: GSK Threatens Access to Weight Loss Supplements

Washington, DC - GlaxoSmithKline, the second-largest pharmaceutical company in the world, has threatened your access to supplements by petitioning the FDA to classify weight loss claims for dietary supplements as ‘disease claims’.

Washington, DC - On April 17th, 2008, pharmaceutical giant GlaxoSmithKline (GSK) submitted a Citizen Petition (yes, we know, GSK is not a citizen) calling for the U.S. Food and Drug Administration (FDA) to reclassify all weight loss support claims for dietary supplements as disease claims. read more

Antioxidant Misinformation

Minneapolis, MN, May 7, 2008 - As natural health consumers, we all know that our vitamins, supplements and nutrients are frequently and consistently targeted by the malicious or misinformed who question their safety or legitimacy. Citizens for Health Senior Policy Advisor, James Gormley, shares his perspective on some of the more recent propaganda. read more

TAKE ACTION: Citizens for Health Joins AHPA in Opposing Irradiation of Supplements

For Immediate Release

Contact: Jim Turner, 202.462.8800

Washington, D.C., December 17, 2007 - Citizens for Health has joined with the American Herbal Products Association in opposing a petition filed with the Food and Drug Administration (FDA) to allow the use of ionizing radiation for the control of microbial contamination on dietary supplements and dietary ingredients. read more

FDA Accepting Comments on Adverse Event Reporting

Washington, D.C., October 15, 2007 - Today the FDA released  and is accepting comments on its guidance on requirements for the reporting of serious adverse events under the Dietary Supplement and Nonprescription Drug Consumer Protection Act.  read more